| 2024-03-01 | Absci Corporation ABSI | director | 222,222 0.1982% | $4.50 | $999,999 | -11.56% | ||
| 2023-12-26 | Fate Therapeutics, Inc. FATE | 44,630 0.0455% | $3.72 | $166,024 | +22.89% | |||
| 2023-11-20 | Augmedix, Inc. AUGX | 1.5M 3.0708% | $4.00 | $6M | -15.67% | |||
| 2023-06-29 | Sale | IGM Biosciences, Inc. IGMS | director | 80,423 0.1809% | $9.42 | $757,585 | -11.25% | |
| 2023-06-29 | IGM Biosciences, Inc. IGMS | director | 80,423 0.1809% | $9.42 | $757,585 | -11.25% | ||
| 2023-04-21 | Fate Therapeutics, Inc. FATE | 256,639 0.26% | $6.18 | $1.59M | -27.09% | |||
| 2023-04-20 | Fate Therapeutics, Inc. FATE | 20,000 0.0204% | $5.99 | $119,800 | -24.29% | |||
| 2023-04-14 | Sale | Fate Therapeutics, Inc. FATE | 302,339 0.2996% | $5.84 | $1.77M | -24.54% | ||
| 2023-04-14 | Fate Therapeutics, Inc. FATE | 25,700 0.0262% | $6.00 | $154,200 | -24.54% | |||
| 2022-10-13 | Zymeworks Inc. ZYME | 10 percent owner | 30,481 0.0481% | $5.03 | $153,435 | +63.8% | ||
| 2021-11-02 | Entrada Therapeutics, Inc. TRDA | 10 percent owner | 2M 25.0465% | $20.00 | $40M | -53.61% | ||
| 2021-10-28 | Augmedix, Inc. AUGX | 1.63M 4.8189% | $4.00 | $6.5M | -34.99% | |||
| 2021-07-26 | Absci Corporation ABSI | director | 1.88M 1.7426% | $16.00 | $30M | -63.43% | ||
| 2021-06-21 | Verve Therapeutics, Inc. VERV | 10 percent owner | 2.1M 13.5677% | $19.00 | $39.9M | -7.41% | ||
| 2021-01-08 | Fate Therapeutics, Inc. FATE | 327,485 0.2577% | $85.50 | $28M | -33.06% | |||
| 2020-12-28 | Sale | Aprea Therapeutics, Inc. APRE | 10 percent owner | 500,000 2.4014% | $5.58 | $2.79M | -11.73% | |
| 2020-10-14 | Shattuck Labs, Inc. STTK | 6.88M 40.0846% | $17.34 | $119.34M | +49.69% | |||
| 2020-10-05 | Augmedix, Inc. AUGX | 5M 11.1027% | $3.00 | $15M | ||||
| 2020-09-09 | IGM Biosciences, Inc. IGMS | 46,520 0.1508% | $52.55 | $2.44M | +48.02% | |||
| 2020-09-08 | IGM Biosciences, Inc. IGMS | 94,226 0.3057% | $49.91 | $4.7M | +56.01% |